• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

Introduction to 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt (CAS No. 1416586-63-4)

The compound 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt (CAS No. 1416586-63-4) is a significant molecule in the field of pharmaceutical chemistry, exhibiting unique structural and functional properties that make it a valuable intermediate in the synthesis of various bioactive agents. This compound belongs to the azetidine class of heterocyclic compounds, which are known for their broad spectrum of biological activities due to their strained ring structure and ability to interact with biological targets in a precise manner.

3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt is particularly noteworthy for its role in the development of novel therapeutic agents. The ethoxy and methyl substituents on the azetidine ring contribute to its chemical reactivity, allowing for further functionalization and diversification of its pharmacological profile. This flexibility has made it a cornerstone in the synthesis of drugs targeting various diseases, including neurological disorders and infectious diseases.

In recent years, there has been a surge in research focusing on the development of small-molecule inhibitors for neurological disorders such as Alzheimer's disease and Parkinson's disease. The azetidine scaffold has shown promise in this area due to its ability to cross the blood-brain barrier and interact with specific enzymes and receptors involved in these conditions. 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt, with its unique structural features, has been explored as a potential lead compound in this context.

One of the most exciting applications of 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt is in the field of antiviral drug development. The compound's ability to mimic natural amino acids has led researchers to investigate its potential as a protease inhibitor, particularly against viruses that rely on protease enzymes for their replication cycle. Preliminary studies have demonstrated that derivatives of this compound exhibit inhibitory activity against several viral proteases, making them promising candidates for further development into antiviral therapies.

The synthesis of 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt involves a series of well-defined chemical reactions that highlight the expertise required in pharmaceutical chemistry. The process typically begins with the formation of the azetidine ring through cyclization reactions, followed by selective substitution with ethoxy and methyl groups. The final step involves conversion to the hydrochloric acid salt form, which enhances the solubility and stability of the compound, making it more suitable for pharmaceutical applications.

Recent advancements in synthetic methodologies have further refined the production of 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt, enabling higher yields and purities. These improvements have been instrumental in facilitating more extensive biological evaluations and clinical trials. The compound's favorable pharmacokinetic properties, including good oral bioavailability and low toxicity, have made it an attractive candidate for further development into novel drugs.

The potential therapeutic applications of 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt extend beyond neurological and antiviral treatments. Researchers are also exploring its utility in oncology, where it has shown promise as a kinase inhibitor. Kinases are enzymes that play critical roles in cell signaling pathways, and dysregulation of these pathways is often associated with cancer development. By inhibiting specific kinases, 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt derivatives may offer a new mechanism for cancer therapy.

In addition to its therapeutic potential, 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt has been investigated for its role in drug discovery as a scaffold for designing novel bioactive molecules. Its structural framework provides a versatile platform for modifications that can enhance binding affinity to target proteins and improve drug-like properties such as solubility and metabolic stability. This makes it an invaluable tool for medicinal chemists seeking to develop next-generation pharmaceuticals.

The growing interest in 3-Ethoxy-3-methyl-azetidine Hydrochloric Acid Salt underscores its importance in modern drug discovery. As research continues to uncover new biological targets and therapeutic strategies, compounds like this will remain at the forefront of pharmaceutical innovation. The combination of its unique chemical properties and promising biological activities makes it a compound worth watching as it progresses through preclinical studies and towards potential clinical applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)